Increasing prevalence of diabetes across the globe is driving the global insulin delivery system market. Further, rising geriatric population coupled with increase in obesity associated with rising improper diet expected to be key factors holding a positive impact on the market growth.Insulin Delivery System Market was valued at US$ 33.1 billion in 2024 and is projected to grow at a CAGR of 9.0% to reach US$ 72.7 billion by 2034.

The report "Insulin Delivery System Market, By Product (Insulin Pen, Insulin Pump, Insulin Syringe, and Others), By Distribution Channel (Hospitals, Diabetes Specialty Clinics, and Retail Channels), and Region - Forecast to 2034"

Key Highlights:

• On April 27, 2019, Medtronic plc launched insulin pump system for Type 1 diabetes patients.
• In March 2018, Ypsomed Holding AG launched “The mylife YpsoPump” insulin pump.

Key Market Insights from the report:          

Insulin Delivery System Market was valued at US$ 33.1 billion in 2024 and is projected to grow at a CAGR of 9.0% to reach US$ 72.7 billion by 2034. The market report has been segmented on the basis of product, distribution channel, and region.

• By product, the insulin pen segment is dominated in the global insulin delivery system market due to technological advancements with regard to insulin pens for better administration of insulin.
• By distribution channel, the hospital segment is accounted for largest share in terms of revenue in the global insulin delivery system market. This is owing to growing investments by hospitals in advanced insulin delivery devices to increase the efficiency of insulin administration.
• By region, North America insulin delivery system market is expected to account for largest share in terms of revenue in the global insulin delivery system market over the forecast period. This can be attributed to rising prevalence of diabetes along with growing demand for technological advanced insulin delivery system in countries of the region. Asia Pacific insulin delivery system market is expected to account for significant share in terms of revenue in the global insulin delivery system market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "Insulin Delivery System Market”, By Product (Insulin Pen, Insulin Pump, Insulin Syringe, and Others), By Distribution Channel (Hospitals, Diabetes Specialty Clinics, and Retail Channels), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2034"

The prominent player operating in the global insulin delivery system market includes ELI Lilly and Company, Ypsomed Holding AG, Becton, Dickinson and Company, Novo Nordisk A/S, Tandem Diabetes Care, Inc., Medtronic plc, Sanofi S.A, Johnson & Johnson, Insulet Corporation, and Biocon Limited.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com